Blog

»  Posts By   December 2015 

Does the Federation of State Medical Board’s Interstate Licensing Compact Enhance Your Ability to Practice Medicine Across State Lines?

In 2015, the Federation of State Medical Boards (FSMB) announced and successfully lobbied for the introduction of the Interstate Licensing Compact (ILC) in order to streamline state licensing procedures for physicians. Understanding and taking advantage of the ILC will allow physicians who wish to engage in the practice of medicine via telehealth technology across state lines a less burdensome barrier to entry. What is the Federation of State Medical Boards?...

Specialty Pharmacy Drug Pricing Continues to be a Hot Topic in Pharmacy Law

Pharmaceutical Manufacturers are facing heightened public and legal scrutiny when it comes to the pricing of Specialty Pharmacy drugs. The issue was thrust into the spotlight in recent months as private Hedge Funds have purchased small Specialty drug companies and raised prices to levels deemed by the public to be egregious. The public outcry against pharmaceutical profiteering has now spread to large publicly traded mainstream manufacturers.  A report released on...

Are Your Physicians Properly Insured? Pending Lawsuit Could Hold Health Care Facilities Liable for Uninsured Physicians

New Jersey law requires all physicians to maintain malpractice insurance for the benefit of patients to whom they provide medical treatment (N.J.S.A. 45:9-19.17). In the alternative, a physician may file a letter of credit in the amount of $500,000 with the Board of Medical Examiners (BME) confirming the physician's financial ability to pay a judgment. Failure to comply with this statute could result in disciplinary action and civil penalties. What...

Partner Daniel Frier Named 2015 Leading Lawyers by Ambulatory M&A Advisor

Partner Daniel B. Frier, Esq., has been recognized by the Ambulatory M&A Advisor with 2015 Leading Lawyer Awards as Top Healthcare Transaction Lawyers of 2015. Started in 2014, the Leading Lawyer Award is a national award that acknowledges healthcare transactions attorneys who have achieved a high degree of recognition and success within the field. Attorneys are nominated by colleagues, clients, and other service professionals within the healthcare transaction field based...

Senate Testimony Highlights Increased Scrutiny of Drug Manufacturers and Drug Pricing

Amid the growing debate surround prescription drug pricing, healthcare practitioners and hospital executives testified this week before a U.S. Senate committee hearing relating to prescription drug pricing. The healthcare stakeholders recounted the ever-increasing prices for many critical generic drugs, and the impact it is having on patient care and access. In the wake of the media focus on Turing Pharmaceuticals, this hearing evidences a likely legislative and regulatory effort to...